Sol-Gel Technologies Ltd

XNAS:SLGL

39.01

-3.29 (-7.78%)

4:10:04 PM EDT: $40.00 +0.99 (+2.54%)

Market Cap (Intraday)	100.22M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$6.5 Million
Adjusted EPS	$0.40

See more estimates

10-Day MA	$40.39
50-Day MA	$37.89
200-Day MA	$18.05

See more pivots

Sol-Gel Technologies Ltd Stock, XNAS:SLGL

Weizmann Science Park, 7 Golda Meir Street, Ness Ziona, Tel Aviv 74036

Israel

Phone: +972.8.931.3433

Number of Employees: 36

http://www.sol-gel.com

Description

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.